| Literature DB >> 32433959 |
Haiwei Zhang1, Xiaoxia Wu1, Xiaoming Li1, Ming Li1, Fang Li1, Lingxia Wang1, Xixi Zhang1, Yue Zhang2, Yan Luo2, Hui Wang3, Yiguo Jiang4, Haibing Zhang5.
Abstract
Receptor-interacting protein kinase 3 (RIPK3) has been identified as an essential regulator of necroptosis, apoptosis, and inflammatory signaling. RIPK3 contains an N-terminal kinase domain and a C-terminal RIP homotypic interaction motif (RHIM). However, the physiological roles of RIPK3 RHIM remain unclear. Here we generate knockin mice endogenously expressing the RIPK3 RHIM mutant, RIPK3V448P. Cells expressing RIPK3V448P are resistant to RIPK1 kinase-dependent apoptosis and necroptosis, and Ripk3V448P/V448P mice rescue embryonic lethality of Fadd-deficient mice by intercrossing. Strikingly, Ripk3V448P/V448PFadd-/- mice display more severe lymphoproliferative disease with a marked increase in abnormal CD3+B220+ lymphocytes compared with Ripk3-/-Fadd-/- mice. More importantly, these inflammatory morbidities in Ripk3V448P/V448PFadd-/- mice are profoundly inhibited by additional deletion of Ripk1. Taken together, these results reveal a previously unidentified physiological function of RHIM of RIPK3 in regulating RIPK1-dependent cell death and lymphoproliferative disease.Entities:
Keywords: FADD; MLKL; RHIM; RIPK1; RIPK3; Receptor-interacting protein homotypic interaction motifs; embryonic development; inflammation; lymphoproliferative disease; necroptosis
Mesh:
Substances:
Year: 2020 PMID: 32433959 DOI: 10.1016/j.celrep.2020.107650
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423